PDGF and PDGF receptors in glioma

References

• Furnari FB, Fenton T, Bachoo RM, Mukasa A, Stommel JM, Stegh A, Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev. 2007;21:2683–710.
   PubMed Web of Science ®Google Scholar
• Heldin CH, Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev. 1999;79:1283–316.
   PubMed Web of Science ®Google Scholar
• Kohler N, Lipton A. Platelets are source of fibroblast growth-promoting activity. Exp Cell Res. 1974;87:297–301.
   PubMed Web of Science ®Google Scholar
• Ross R, Glomset J, Kariya B, Harker L. A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc Natl Acad Sci USA. 1974;71:1207–10.
   PubMed Web of Science ®Google Scholar
• Westermark B, Wasteson A. A platelet factor stimulating human normal glial cells. Exp Cell Res. 1976;98:170–4.
   PubMed Web of Science ®Google Scholar
• Andrae J, Gallini R, Betsholtz C. Role of platelet-derived growth factors in physiology and medicine. Genes Dev. 2008;22:1276–312.
   PubMed Web of Science ®Google Scholar
• Fredriksson L, Li H, Eriksson U. The PDGF family: four gene products form five dimeric isoforms. Cytokine Growth Factor Rev. 2004;15:197–204.
   PubMed Web of Science ®Google Scholar
• Bergsten E, Uutela M, Li X, Pietras K, Ostman A, Heldin CH, PDGF-D is a specific, protease-activated ligand for the PDGF beta-receptor. Nat Cell Biol. 2001;3:512–16.
   PubMed Web of Science ®Google Scholar
• Li X, Pontén A, Aase K, Karlsson L, Abramsson A, Uutela M, PDGF-C is a new protease-activated ligand for the PDGF alpha-receptor. Nat Cell Biol. 2000;2:302–9.
   PubMed Web of Science ®Google Scholar
• LaRochelle WJ, May-Siroff M, Robbins KC, Aaronson SA. A novel mechanism regulating growth factor association with the cell surface: identification of a PDGF retention domain. Genes Dev. 1991;5:1191–9.
   PubMed Web of Science ®Google Scholar
• Ostman A, Andersson M, Betsholtz C, Westermark B, Heldin CH. Identification of a cell retention signal in the B-chain of platelet-derived growth factor and in the long splice version of the A-chain. Cell Regul. 1991;2:503–12.
   PubMedGoogle Scholar
• Andersson M, Ostman A, Westermark B, Heldin CH. Characterization of the retention motif in the C-terminal part of the long splice form of platelet-derived growth factor A-chain. J Biol Chem. 1994;269:926–30.
   PubMed Web of Science ®Google Scholar
• Rorsman F, Bywater M, Knott TJ, Scott J, Betsholtz C. Structural characterization of the human platelet-derived growth factor A-chain cDNA and gene: alternative exon usage predicts two different precursor proteins. Mol Cell Biol. 1988;8:571–7.
   PubMed Web of Science ®Google Scholar
• Claesson-Welsh L. Platelet-derived growth factor receptor signals. J Biol Chem. 1994;269:32023–6.
   PubMed Web of Science ®Google Scholar
• Heldin CH, Westermark B, Wasteson A. Platelet-derived growth factor: purification and partial characterization. Proc Natl Acad Sci USA. 1979;76:3722–6.
   PubMed Web of Science ®Google Scholar
• Westermark B, Magnusson A, Heldin CH. Effect of epidermal growth factor on membrane motility and cell locomotion in cultures of human clonal glioma cells. J Neurosci Res. 1982;8:491–507.
   PubMed Web of Science ®Google Scholar
• Westermark B, Pontén J, Hugosson R. Determinants for the establishment of permanent tissue culture lines from human gliomas. Acta Pathol Microbiol Scand A. 1973;81:791–805.
   PubMedGoogle Scholar
• Nister M, Heldin CH, Wasteson A, Westermark B. A platelet-derived growth factor analog produced by a human clonal glioma cell line. Ann NY Acad Sci. 1982;397:25–33.
   PubMed Web of Science ®Google Scholar
• Nistér M, Heldin CH, Wasteson A, Westermark B. A glioma-derived analog to platelet-derived growth factor: demonstration of receptor competing activity and immunological crossreactivity. Proc Natl Acad Sci USA. 1984;81:926–30.
   PubMed Web of Science ®Google Scholar
• Dalla-Favera R, Gelmann EP, Gallo RC, Wong-Staal F. A human onc gene homologous to the transforming gene (v-sis) of simian sarcoma virus. Nature. 1981;292:31–5.
   PubMed Web of Science ®Google Scholar
• Waterfield MD, Scrace GT, Whittle N, Stroobant P, Johnsson A, Wasteson A, Platelet-derived growth factor is structurally related to the putative transforming protein p28sis of simian sarcoma virus. Nature. 1983;304:35–9.
   PubMed Web of Science ®Google Scholar
• Ek B, Westermark B, Wasteson A, Heldin CH. Stimulation of tyrosine-specific phosphorylation by platelet-derived growth factor. Nature. 1982;295:419–20.
   PubMed Web of Science ®Google Scholar
• Downward J, Yarden Y, Mayes E, Scrace G, Totty N, Stockwell P, Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences. Nature. 1984;307:521–7.
   PubMed Web of Science ®Google Scholar
• Theilen GH, Gould D, Fowler M, Dungworth DL. C-type virus in tumor tissue of a woolly monkey (Lagothrix spp.) with fibrosarcoma. J Natl Cancer Inst. 1971;47:881–9.
   PubMed Web of Science ®Google Scholar
• Nistér M, Hammacher A, Mellström K, Siegbahn A, Rönnstrand L, Westermark B, A glioma-derived PDGF A chain homodimer has different functional activities from a PDGF AB heterodimer purified from human platelets. Cell. 1988;52:791–9.
   PubMed Web of Science ®Google Scholar
• Hammacher A, Nistér M, Westermark B, Heldin CH. A human glioma cell line secretes three structurally and functionally different dimeric forms of platelet-derived growth factor. Eur J Biochem. 1988;176:179–86.
   PubMedGoogle Scholar
• Betsholtz C, Johnsson A, Heldin CH, Westermark B, Lind P, Urdea MS, cDNA sequence and chromosomal localization of human platelet-derived growth factor A-chain and its expression in tumour cell lines. Nature. 1986;320:695–9.
   PubMed Web of Science ®Google Scholar
• Rorsman F, Leveen P, Betsholtz C. Platelet-derived growth factor (PDGF) A-chain mRNA heterogeneity generated by the use of alternative promoters and alternative polyadenylation sites. Growth Factors. 1992;7:241–51.
   PubMed Web of Science ®Google Scholar
• Nistér M, Heldin CH, Westermark B. Clonal variation in the production of a platelet-derived growth factor-like protein and expression of corresponding receptors in a human malignant glioma. Cancer Res. 1986;46:332–40.
   PubMed Web of Science ®Google Scholar
• Claesson-Welsh L, Hammacher A, Westermark B, Heldin CH, Nistér M. Identification and structural analysis of the A type receptor for platelet-derived growth factor. Similarities with the B type receptor. J Biol Chem. 1989;264:1742–7.
   PubMed Web of Science ®Google Scholar
• Claesson-Welsh L, Eriksson A, Westermark B, Heldin CH. cDNA cloning and expression of the human A-type platelet-derived growth factor (PDGF) receptor establishes structural similarity to the B-type PDGF receptor. Proc Natl Acad Sci USA. 1989;86:4917–21.
   PubMed Web of Science ®Google Scholar
• Matsui T, Heidaran M, Miki T, Popescu N, La Rochelle W, Kraus M, Isolation of a novel receptor cDNA establishes the existence of two PDGF receptor genes. Science. 1989;243:800–4.
   PubMed Web of Science ®Google Scholar
• Nister M, Libermann T, Betsholtz C, Pettersson M, Claesson-Welsh L, Heldin CH, Expression of messenger RNAs for platelet-derived growth factor and transforming growth factor-alpha and their receptors in human malignant glioma cell lines. Cancer Res. 1988;48:3910–18.
   PubMed Web of Science ®Google Scholar
• Hermanson M, Nistér M, Betsholtz C, Heldin CH, Westermark B, Funa K. Endothelial cell hyperplasia in human glioblastoma: coexpression of mRNA for platelet-derived growth factor (PDGF) B chain and PDGF receptor suggests autocrine growth stimulation. Proc Natl Acad Sci USA. 1988;85:7748–52.
   PubMed Web of Science ®Google Scholar
• Hermanson M, Funa K, Hartman M, Claesson-Welsh L, Heldin CH, Westermark B, Platelet-derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops. Cancer Res. 1992;52:3213–19.
   PubMed Web of Science ®Google Scholar
• Hermanson M, Funa K, Koopmann J, Maintz D, Waha A, Westermark B, Association of loss of heterozygosity on chromosome 17p with high platelet-derived growth factor alpha receptor expression in human malignant gliomas. Cancer Res. 1996;56:164–71.
   PubMed Web of Science ®Google Scholar
• De Bustos C, Smits A, Strömberg B, Collins VP, Nistér M, Afink G. A PDGFRA promoter polymorphism, which disrupts the binding of ZNF148, is associated with primitive neuroectodermal tumours and ependymomas. J Med Genet. 2005;42:31–7.
   PubMed Web of Science ®Google Scholar
• Toepoel M, Joosten PH, Knobbe CB, Afink GB, Zotz RB, Steegers-Theunissen RP, Haplotype-specific expression of the human PDGFRA gene correlates with the risk of glioblastomas. Int J Cancer. 2008;123:322–9.
   PubMed Web of Science ®Google Scholar
• Fleming TP, Saxena A, Clark WC, Robertson JT, Oldfield EH, Aaranson SA, Amplification and/or overexpression of platelet-derived growth factor receptors and epidermal growth factor receptor in human glial tumors. Cancer Res. 1992;52:4550–3.
   PubMed Web of Science ®Google Scholar
• Lokker NA, Sullivan CM, Hollenbach SJ, Israel MA, Giese NA. Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors. Cancer Res. 2002;62:3729–35.
   PubMed Web of Science ®Google Scholar
• Beckmann MP, Betsholtz C, Heldin C-H, Westermark B, Di Marco E, Di Fiore PP, Comparison of biological properties and transforming potential of human PDGF-A and PDGF-B chains. Science. 1988;241:1346–9.
   PubMed Web of Science ®Google Scholar
• Vassbotn FS, Ostman A, Langeland N, Holmsen H, Westermark B, Heldin CH, Activated platelet-derived growth factor autocrine pathway drives the transformed phenotype of a human glioblastoma cell line. J Cell Physiol. 1994;158:381–9.
   PubMed Web of Science ®Google Scholar
• Strawn LM, Mann E, Elliger SS, Chu LM, Germain LL, Niederfellner G, Inhibition of glioma cell growth by a truncated platelet-derived growth factor-beta receptor. J Biol Chem. 1994;269:21215–22.
   PubMed Web of Science ®Google Scholar
• Dresemann G, Weller M, Rosenthal MA, Wedding U, Wagner W, Engel E, Imatinib in combination with hydroxyurea versus hydroxyurea alone as oral therapy in patients with progressive pretreated glioblastoma resistant to standard dose temozolomide. J Neurooncol. 2010;96:393–402.
   PubMed Web of Science ®Google Scholar
• Reardon DA, Dresemann G, Taillibert S, Campone M, van den Bent M, Clement P, Multicentre phase II studies evaluating imatinib plus hydroxyurea in patients with progressive glioblastoma. Br J Cancer. 2009;101:1995–2004.
   PubMed Web of Science ®Google Scholar
• Hägerstrand D, He X, Bradic Lindh M, Hoefs S, Hesselager G, Ostman A, Identification of a SOX2-dependent subset of tumor- and sphere-forming glioblastoma cells with a distinct tyrosine kinase inhibitor sensitivity profile. Neuro Oncol. 2011;13:11178–91.
   Web of Science ®Google Scholar
• Holmberg J, He X, Peredo I, Orrego A, Hesselager G, Ericsson C, Activation of neural and pluripotent stem cell signatures correlates with increased malignancy in human glioma. PLoS ONE. 2011;6:e18454.
   Web of Science ®Google Scholar
• Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663–76.
   PubMed Web of Science ®Google Scholar
• Betsholtz C. Insight into the physiological functions of PDGF through genetic studies in mice. Cytokine Growth Factor Rev. 2004;15:215–28.
   PubMed Web of Science ®Google Scholar
• Bostrom H, Willetts K, Pekny M, Leveen P, Lindahl P, Hedstrand H, PDGF-A signaling is a critical event in lung alveolar myofibroblast development and alveogenesis. Cell. 1996;85:863–73.
   PubMed Web of Science ®Google Scholar
• Ding H, Wu X, Boström H, Kim I, Wong N, Tsoi B, A specific requirement for PDGF-C in palate formation and PDGFR-alpha signaling. Nat Genet. 2004;36:1111–16.
   PubMed Web of Science ®Google Scholar
• Levéen P, Pekny M, Gebre-Medhin S, Swolin B, Larsson E, Betsholtz C. Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities. Genes Dev. 1994;8:1875–87.
   PubMed Web of Science ®Google Scholar
• Soriano P. Abnormal kidney development and hematological disorders in PDGF beta-receptor mutant mice. Genes Dev. 1994;8:1888–96.
   PubMed Web of Science ®Google Scholar
• Soriano P. The PDGF alpha receptor is required for neural crest cell development and for normal patterning of the somites. Development. 1997;124:2691–700.
   PubMed Web of Science ®Google Scholar
• Lindahl P, Johansson BR, Levéen P, Betsholtz C. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science. 1997;277:242–5.
   PubMed Web of Science ®Google Scholar
• Lindahl P, Karlsson L, Hellström M, Gebre-Medhin S, Willetts K, Heath JK, Alveogenesis failure in PDGF-A-deficient mice is coupled to lack of distal spreading of alveolar smooth muscle cell progenitors during lung development. Development. 1997;124:3943–53.
   PubMed Web of Science ®Google Scholar
• Klinghoffer RA, Mueting-Nelson PF, Faerman A, Shani M, Soriano P. The two PDGF receptors maintain conserved signaling in vivo despite divergent embryological functions. Mol Cell. 2001;7:343–54.
   PubMed Web of Science ®Google Scholar
• Klinghoffer RA, Hamilton TG, Hoch R, Soriano P. An allelic series at the PDGFalphaR locus indicates unequal contributions of distinct signaling pathways during development. Dev Cell. 2002;2:103–13.
   PubMed Web of Science ®Google Scholar
• Göritz C, Dias DO, Tomilin N, Barbacid M, Shupliakov O, Frisén J. A pericyte origin of spinal cord scar tissue. Science. 2011;333:238–42.
   PubMed Web of Science ®Google Scholar
• Sasahara M, Fries JW, Raines EW, Gown AM, Westrum LE, Frosch MP, PDGF B-chain in neurons of the central nervous system, posterior pituitary, and in a transgenic model. Cell. 1991;64:217–27.
   PubMedGoogle Scholar
• Egawa-Tsuzuki T, Ohno M, Tanaka N, Takeuchi Y, Uramoto H, Faigle R, The PDGF B-chain is involved in the ontogenic susceptibility of the developing rat brain to NMDA toxicity. Exp Neurol. 2004;186:89–98.
   PubMed Web of Science ®Google Scholar
• Ishii Y, Oya T, Zheng L, Gao Z, Kawaguchi M, Sabit H, Mouse brains deficient in neuronal PDGF receptor-beta develop normally but are vulnerable to injury. J Neurochem. 2006;98:588–600.
   PubMed Web of Science ®Google Scholar
• Smits A, Kato M, Westermark B, Nister M, Heldin CH, Funa K. Neurotrophic activity of platelet-derived growth factor (PDGF): Rat neuronal cells possess functional PDGF beta-type receptors and respond to PDGF. Proc Natl Acad Sci USA. 1991;88:8159–63.
   PubMed Web of Science ®Google Scholar
• Hellström M, Kalén M, Lindahl P, Abramsson A, Betsholtz C. Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development. 1999;126:3047–55.
   PubMed Web of Science ®Google Scholar
• Smits A, Hermansson M, Nistér M, Karnushina I, Heldin CH, Westermark B, Rat brain capillary endothelial cells express functional PDGF B-type receptors. Growth Factors. 1989;2:1–8.
   PubMed Web of Science ®Google Scholar
• Fruttiger M, Calver AR, Richardson WD. Platelet-derived growth factor is constitutively secreted from neuronal cell bodies but not from axons. Curr Biol. 2000;10:1283–6.
   PubMed Web of Science ®Google Scholar
• Noble M, Murray K, Stroobant P, Waterfield MD, Riddle P. Platelet-derived growth factor promotes division and motility and inhibits premature differentiation of the oligodendrocyte/type-2 astrocyte progenitor cell. Nature. 1988;333:560–2.
   PubMed Web of Science ®Google Scholar
• Yeh H-J, Ruit KG, Wang Y-X, Parks WC, Snider WD, Deuel TF. PDGF A-chain gene is expressed by mammalian neurons during development and in maturity. Cell. 1991;64:209–16.
   PubMed Web of Science ®Google Scholar
• Raff MC, Lillien L, Richardson WD, Burne JF, Noble M. Platelet-derived growth factor from astrocytes drives the lock that times oligodendrocyte development in culture. Nature. 1988;333:562–5.
   PubMed Web of Science ®Google Scholar
• Richardson WD, Pringle N, Mosley MJ, Westermark B, Dubois-Dalcq M. A role for platelet-derived growth factor in normal gliogenesis in the central nervous system. Cell. 1988;53:309–19.
   PubMed Web of Science ®Google Scholar
• Calver AR, Hall AC, Yu WP, Walsh FS, Heath JK, Betsholtz C, Oligodendrocyte population dynamics and the role of PDGF in vivo. Neuron. 1998;20:869–82.
   PubMed Web of Science ®Google Scholar
• Fruttiger M, Karlsson L, Hall AC, Abramsson A, Calver AR, Bostrom H, Defective oligodendrocyte development and severe hypomyelination in PDGF-A knockout mice. Development. 1999;126:457–67.
   PubMed Web of Science ®Google Scholar
• van Heyningen P, Calver AR, Richardson WD. Control of progenitor cell number by mitogen supply and demand. Curr Biol. 2001;11:232–41.
   PubMed Web of Science ®Google Scholar
• Woodruff RH, Fruttiger M, Richardson WD, Franklin JM. Platelet-derived growth factor regulates oligodendrocyte progenitor number in adult CNS and their response following CNS demyelination. Mol Cell Neurosci. 2004;25:252–62.
   PubMed Web of Science ®Google Scholar
• Hu JG, Fu SL, Wang YX, Li Y, Jiang XY, Wang XF, Platelet-derived growth factor-AA mediates oligodendrocyte lineage differentiation through activation of extracellular signal-regulated kinase signaling pathway. Neuroscience. 2008;151:138–47.
   PubMed Web of Science ®Google Scholar
• Jackson EL, Garcia-Verdugo JM, Gil-Perotin S, Roy M, Quinones-Hinojosa A, VandenBerg S, PDGFR alpha-positive B cells are neural stem cells in the adult SVZ that form glioma-like growths in response to increased PDGF signaling. Neuron. 2006;51:187–99.
   PubMed Web of Science ®Google Scholar
• Menn B, Garcia-Verdugo JM, Yaschine C, Gonzalez-Perez O, Rowitch D, Alvarez-Buylla A. Origin of oligodendrocytes in the subventricular zone of the adult brain. J Neurosci. 2006;26:7907–18.
   PubMed Web of Science ®Google Scholar
• Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114:97–109.
   PubMed Web of Science ®Google Scholar
• Ohgaki H, Kleihues P. Genetic pathways to primary and secondary glioblastoma. Am J Pathol. 2007;170:1445–53.
   PubMed Web of Science ®Google Scholar
• Ekstrand AJ, James CD, Cavenee WK, Seliger B, Pettersson RF, Collins VP. Genes for epidermal growth factor receptor, transforming growth factor alpha, and epidermal growth factor and their expression in human gliomas in vivo. Cancer Res. 1991;51:2164–72.
   PubMed Web of Science ®Google Scholar
• Libermann TA, Razon N, Bartal AD, Yarden Y, Schlessinger J, Soreq H. Expression of epidermal growth factor receptors in human brain tumors. Cancer Res. 1984;44:753–60.
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008;455:1061–8.
   PubMed Web of Science ®Google Scholar
• Wong AJ, Ruppert JM, Bigner SH, Grzeschik CH, Humphrey PA, Bigner DS, Structural alterations of the epidermal growth factor receptor gene in human gliomas. Proc Natl Acad Sci USA. 1992;89:2965–9.
   PubMed Web of Science ®Google Scholar
• Sugawa N, Ekstrand AJ, James CD, Collins VP. Identical splicing of aberrant epidermal growth factor receptor transcripts from amplified rearranged genes in human glioblastomas. Proc Natl Acad Sci USA. 1990;87:8602–6.
   PubMed Web of Science ®Google Scholar
• Gan HK, Kaye AH, Luwor RB. The EGFRvIII variant in glioblastoma multiforme. J Clin Neurosci. 2009;16:748–54.
   PubMed Web of Science ®Google Scholar
• Di Rocco F, Carroll RS, Zhang J, Black PM. Platelet-derived growth factor and its receptor expression in human oligodendrogliomas. Neurosurgery. 1998;42:341–6.
   PubMed Web of Science ®Google Scholar
• Martinho O, Longatto-Filho A, Lambros MB, Martins A, Pinheiro C, Silva A, Expression, mutation and copy number analysis of platelet-derived growth factor receptor A (PDGFRA) and its ligand PDGFA in gliomas. Br J Cancer. 2009;101:973–82.
   PubMed Web of Science ®Google Scholar
• Kumabe T, Sohma Y, Kayama T, Yoshimoto T, Yamamoto T. Overexpression and amplification of alpha-PDGF receptor gene lacking exons coding for a portion of the extracellular region in a malignant glioma. Tohoku J Exp Med. 1992;168:265–9.
   PubMed Web of Science ®Google Scholar
• Rand V, Huang J, Stockwell T, Ferriera S, Buzko O, Levy S, Sequence survey of receptor tyrosine kinases reveals mutations in glioblastomas. Proc Natl Acad Sci USA. 2005;102:14344–9.
   PubMed Web of Science ®Google Scholar
• Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, Cancer Genome Atlas Research Network. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 2010;17:98–110.
   PubMed Web of Science ®Google Scholar
• Ozawa T, Brennan CW, Wang L, Squatrito M, Sasayama T, Nakada M, PDGFRA gene rearrangements are frequent genetic events in PDGFRA-amplified glioblastomas. Genes Dev. 2010;24:2205–18.
   PubMed Web of Science ®Google Scholar
• Sørensen SA, Mulvihill JJ, Nielsen A. Long-term follow-up of von Recklinghausen neurofibromatosis. Survival and malignant neoplasms. N Engl J Med. 1986;314:1010–15.
   PubMed Web of Science ®Google Scholar
• Knobbe CB, Reifenberger G. Genetic alterations and aberrant expression of genes related to the phosphatidyl-inositol-3'-kinase/protein kinase B (Akt) signal transduction pathway in glioblastomas. Brain Pathol. 2003;13:507–18.
   PubMed Web of Science ®Google Scholar
• Zundel W, Schindler C, Haas-Kogan D, Koong A, Kaper F, Chen E, Loss of PTEN facilitates HIF-1-mediated gene expression. Genes Dev. 2000;14:391–6.
   PubMed Web of Science ®Google Scholar
• Rich JN, Bigner DD. Development of novel targeted therapies in the treatment of malignant glioma. Nat Rev Drug Discov. 2004;3:430–46.
   PubMed Web of Science ®Google Scholar
• Watanabe K, Tachibana O, Sata K, Yonekawa Y, Kleihues P, Ohgaki H. Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas. Brain Pathol. 1996;6:217–23; discussion 23–4.
   PubMed Web of Science ®Google Scholar
• Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P, An integrated genomic analysis of human glioblastoma multiforme. Science. 2008;321:1807–12.
   PubMed Web of Science ®Google Scholar
• Zheng H, Ying H, Yan H, Kimmelman AC, Hiller DJ, Chen AJ, p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation. Nature. 2008;455:1129–33.
   PubMed Web of Science ®Google Scholar
• Ohgaki H, Dessen P, Jourde B, Horstmann S, Nishikawa T, Di Patre PL, Genetic pathways to glioblastoma: a population-based study. Cancer Res. 2004;64:6892–9.
   PubMed Web of Science ®Google Scholar
• von Deimling A, Eibl RH, Ohgaki H, Louis DN, von Ammon K, Petersen I, p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma. Cancer Res. 1992;52:2987–90.
   PubMed Web of Science ®Google Scholar
• Soussi T, Wiman KG. Shaping genetic alterations in human cancer: the p53 mutation paradigm. Cancer Cell. 2007;12:303–12.
   PubMed Web of Science ®Google Scholar
• Brennan C, Momota H, Hambardzumyan D, Ozawa T, Tandon A, Pedraza A, Glioblastoma subclasses can be defined by activity among signal transduction pathways and associated genomic alterations. PLoS ONE. 2009;4:e7752.
   PubMed Web of Science ®Google Scholar
• Phillips HS, Kharbanda S, Chen R, Forrest WF, Soriano RH, Wu TD, Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell. 2006;9:157–73.
   PubMed Web of Science ®Google Scholar
• Robertson T, Koszyca B, Gonzales M. Overview and recent advances in neuropathology. Part 1: Central nervous system tumours. Pathology. 2011;43:88–92.
   PubMed Web of Science ®Google Scholar
• Brennan C. Genomic profiles of glioma. Curr Neurol Neurosci Rep. 2011;11:291–7.
   PubMed Web of Science ®Google Scholar
• Huse JT, Phillips HS, Brennan CW. Molecular subclassification of diffuse gliomas: seeing order in the chaos. Glia. 2011;59:1190–9.
   PubMed Web of Science ®Google Scholar
• Van Meir EG, Hadjipanayis CG, Norden AD, Shu HK, Wen PY, Olson JJ. Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma. CA Cancer J Clin. 2010;60:166–93.
   PubMed Web of Science ®Google Scholar
• Altman J. Are new neurons formed in the brains of adult mammals? Science. 1962;135:1127–8.
   PubMed Web of Science ®Google Scholar
• Morshead CM, Reynolds BA, Craig CG, McBurney MW, Staines WA, Morassutti D, Neural stem cells in the adult mammalian forebrain: a relatively quiescent subpopulation of subependymal cells. Neuron. 1994;13:1071–82.
   PubMed Web of Science ®Google Scholar
• Reynolds BA, Weiss S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science. 1992;255:1707–10.
   PubMed Web of Science ®Google Scholar
• Curtis MA, Kam M, Nannmark U, Anderson MF, Axell MZ, Wikkelso C, Human neuroblasts migrate to the olfactory bulb via a lateral ventricular extension. Science. 2007;315:1243–9.
   PubMed Web of Science ®Google Scholar
• Doetsch F, Caille I, Lim DA, Garcia-Verdugo JM, Alvarez-Buylla A. Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell. 1999;97:703–16.
   PubMed Web of Science ®Google Scholar
• Johansson CB, Momma S, Clarke DL, Risling M, Lendahl U, Frisén J. Identification of a neural stem cell in the adult mammalian central nervous system. Cell. 1999;96:25–34.
   PubMed Web of Science ®Google Scholar
• Merkle FT, Tramontin AD, García-Verdugo JM, Alvarez-Buylla A. Radial glia give rise to adult neural stem cells in the subventricular zone. Proc Natl Acad Sci USA. 2004;101:17528–32.
   PubMed Web of Science ®Google Scholar
• Ellis P, Fagan BM, Magness ST, Hutton S, Taranova O, Hayashi S, SOX2, a persistent marker for multipotential neural stem cells derived from embryonic stem cells, the embryo or the adult. Dev Neurosci. 2004;26:148–65.
   PubMed Web of Science ®Google Scholar
• Suh H, Consiglio A, Ray J, Sawai T, D'Amour KA, Gage FH. In vivo fate analysis reveals the multipotent and self-renewal capacities of Sox2+ neural stem cells in the adult hippocampus. Cell Stem Cell. 2007;1:515–28.
   PubMed Web of Science ®Google Scholar
• Favaro R, Valotta M, Ferri AL, Latorre E, Mariani J, Giachino C, Hippocampal development and neural stem cell maintenance require Sox2-dependent regulation of Shh. Nat Neurosci. 2009;12:1248–56.
   PubMed Web of Science ®Google Scholar
• Ferri AL, Cavallaro M, Braida D, Di Cristofano A, Canta A, Vezzani A, Sox2 deficiency causes neurodegeneration and impaired neurogenesis in the adult mouse brain. Development. 2004;131:3805–19.
   PubMed Web of Science ®Google Scholar
• Doetsch F. A niche for adult neural stem cells. Curr Opin Genet Dev. 2003;13:543–50.
   PubMed Web of Science ®Google Scholar
• Riquelme PA, Drapeau E, Doetsch F. Brain micro-ecologies: neural stem cell niches in the adult mammalian brain. Philos Trans R Soc Lond B Biol Sci. 2008;363:123–37.
   PubMed Web of Science ®Google Scholar
• Ramírez-Castillejo C, Sánchez-Sánchez F, Andreu-Agulló C, Ferrón SR, Aroca-Aguilar JD, Sánchez P, Pigment epithelium-derived factor is a niche signal for neural stem cell renewal. Nat Neurosci. 2006;9:331–9.
   PubMed Web of Science ®Google Scholar
• Shen Q, Goderie SK, Jin L, Karanth N, Sun Y, Abramova N, Endothelial cells stimulate self-renewal and expand neurogenesis of neural stem cells. Science. 2004;304:1338–40.
   PubMed Web of Science ®Google Scholar
• Doetsch F, Petreanu L, Caille I, Garcia-Verdugo JM, Alvarez-Buylla A. EGF converts transit-amplifying neurogenic precursors in the adult brain into multipotent stem cells. Neuron. 2002;36:1021–34.
   PubMed Web of Science ®Google Scholar
• Craig CG, Tropepe V, Morshead CM, Reynolds BA, Weiss S, van der Kooy D. In vivo growth factor expansion of endogenous subependymal neural precursor cell populations in the adult mouse brain. J Neurosci. 1996;16:2649–58.
   PubMed Web of Science ®Google Scholar
• Erlandsson A, Enarsson M, Forsberg-Nilsson K. Immature neurons from CNS stem cells proliferate in response to platelet-derived growth factor. J Neurosci. 2001;21:3483–91.
   PubMed Web of Science ®Google Scholar
• Kuhn HG, Winkler J, Kempermann G, Thal LJ, Gage FH. Epidermal growth factor and fibroblast growth factor-2 have different effects on neural progenitors in the adult rat brain. J Neurosci. 1997;17:5820–9.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Perez O, Romero-Rodriguez R, Soriano-Navarro M, Garcia-Verdugo JM, Alvarez-Buylla A. Epidermal growth factor induces the progeny of subventricular zone type B cells to migrate and differentiate into oligodendrocytes. Stem Cells. 2009;27:2032–43.
   PubMed Web of Science ®Google Scholar
• Bachoo RM, Maher EH, Ligon KL, Sharpless NE, Chan SS, You MJ, Epidermal growth factor receptor and Ink4a/Arf: convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis. Cancer Cell. 2002;1:269–77.
   PubMed Web of Science ®Google Scholar
• Dai C, Celestino JC, Okada Y, Louis DN, Fuller GN, Holland EC. PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo. Genes Dev. 2001;15:1913–25.
   PubMed Web of Science ®Google Scholar
• D'Sa-Eipper C, Leonard JR, Putcha G, Zheng TS, Flavell RA, Rakic P, DNA damage-induced neural precursor cell apoptosis requires p53 and caspase 9 but neither Bax nor caspase 3. Development. 2001;128:137–46.
   PubMed Web of Science ®Google Scholar
• Armstrong JF, Kaufman MH, Harrison DJ, Clarke AR. High-frequency developmental abnormalities in p53-deficient mice. Curr Biol. 1995;5:931–6.
   PubMed Web of Science ®Google Scholar
• Sah VP, Attardi LD, Mulligan GJ, Williams BO, Bronson RT, Jacks T. A subset of p53-deficient embryos exhibit exencephaly. Nat Genet. 1995;10:175–80.
   PubMed Web of Science ®Google Scholar
• Meletis K, Wirta V, Hede SM, Nistér M, Lundeberg J, Frisén J. p53 suppresses the self-renewal of adult neural stem cells. Development. 2006;133:363–9.
   PubMed Web of Science ®Google Scholar
• Bonavia R, Inda MM, Cavenee WK, Furnari FB. Heterogeneity maintenance in glioblastoma: a social network. Cancer Res. 2011;71:4055–60.
   PubMed Web of Science ®Google Scholar
• Beier D, Hau P, Proescholdt M, Lohmeier A, Wischhusen J, Oefner PJ, CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res. 2007;67:4010–15.
   PubMed Web of Science ®Google Scholar
• Chen R, Nishimura MC, Bumbaca SM, Kharbanda S, Forrest WF, Kasman IM, A hierarchy of self-renewing tumor-initiating cell types in glioblastoma. Cancer Cell. 2010;17:362–75.
   PubMed Web of Science ®Google Scholar
• Clarke DL, Johansson CB, Wilbertz J, Veress B, Nilsson E, Karlström H, Generalized potential of adult neural stem cells. Science. 2000;288:1660–3.
   PubMed Web of Science ®Google Scholar
• Galli R, Binda E, Orfanelli U, Cipelletti B, Gritti A, De Vitis S, Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res. 2004;64:7011–21.
   PubMed Web of Science ®Google Scholar
• Mazzoleni S, Politi LS, Pala M, Cominelli M, Franzin A, Sergi Sergi L, Epidermal growth factor receptor expression identifies functionally and molecularly distinct tumor-initiating cells in human glioblastoma multiforme and is required for gliomagenesis. Cancer Res. 2010;70:7500–13.
   Google Scholar
• Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Identification of human brain tumour initiating cells. Nature. 2004;432:396–401.
   PubMed Web of Science ®Google Scholar
• Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature. 2006;444:756–60.
   PubMed Web of Science ®Google Scholar
• Lindberg N, Kastemar M, Olofsson T, Smits A, Uhrbom L. Oligodendrocyte progenitor cells can act as cell of origin for experimental glioma. Oncogene. 2009;28:2266–75.
   PubMed Web of Science ®Google Scholar
• Seidel S, Garvalov BK, Wirta V, von Stechow L, Schänzer A, Meletis K, A hypoxic niche regulates glioblastoma stem cells through hypoxia inducible factor 2 alpha. Brain. 2010;133:983–95.
   PubMed Web of Science ®Google Scholar
• Oka N, Soeda A, Inagaki A, Onodera M, Maruyama H, Hara A, VEGF promotes tumorigenesis and angiogenesis of human glioblastoma stem cells. Biochem Biophys Res Commun. 2007;360:553–9.
   PubMed Web of Science ®Google Scholar
• Calabrese C, Poppleton H, Kocak M, Hogg TL, Fuller C, Hamner B, A perivascular niche for brain tumor stem cells. Cancer Cell. 2007;11:69–82.
   PubMed Web of Science ®Google Scholar
• Bao S, Wu Q, Li Z, Sathornsumetee S, Wang H, McLendon RE, Targeting cancer stem cells through L1CAM suppresses glioma growth. Cancer Res. 2008;68:6043–8.
   PubMed Web of Science ®Google Scholar
• Xie Z. Brain tumor stem cells. Neurochem Res. 2009;34:2055–66.
   PubMed Web of Science ®Google Scholar
• Deinhardt F. The biology of primate retroviruses. In: Klein G. editor. Viral Oncology. New York: Raven press; 1980. p 359–98.
   Google Scholar
• Nistér M, Westermark B. Mechanisms of altered growth control; Growth factors. In Bigner DD, McLendon RE, Bruner JM, editors. Pathology of tumors of the nervous system. 6th ed. Vol 1. London: Arnold, Hodder Headline Group; 1998. p 83–116.
   Google Scholar
• Uhrbom L, Hesselager G, Nister M, Westermark B. Induction of brain tumors in mice using a recombinant platelet-derived growth factor B-chain retrovirus. Cancer Res. 1998;58:5275–9.
   PubMed Web of Science ®Google Scholar
• Uhrbom L, Hesselager G, Ostman A, Nister M, Westermark B. Dependence of autocrine growth factor stimulation in platelet-derived growth factor-B-induced mouse brain tumor cells. Int J Cancer. 2000;85:398–406.
   PubMed Web of Science ®Google Scholar
• Fisher GH, Orsulic S, Holland E, Hively WP, Li Y, Lewis BC, Development of a flexible and specific gene delivery system for production of murine tumor models. Oncogene. 1999;18:5253–60.
   PubMed Web of Science ®Google Scholar
• Uhrbom L, Holland EC. Modeling gliomagenesis with somatic cell gene transfer using retroviral vectors. J Neurooncol. 2001;53:297–305.
   PubMed Web of Science ®Google Scholar
• Hesselager G, Uhrbom L, Westermark B, Nistér M. Complementary effects of platelet-derived growth factor autocrine stimulation and p53 or Ink4a-Arf deletion in a mouse glioma model. Cancer Res. 2003;63:4305–9.
   PubMed Web of Science ®Google Scholar
• See WL, Miller JP, Squatrito M, Holland E, Resh MD, Koff A. Defective DNA double-strand break repair underlies enhanced tumorigenesis and chromosomal instability in p27-deficient mice with growth factor-induced oligodendrogliomas. Oncogene. 2010;29:1720–31.
   PubMed Web of Science ®Google Scholar
• Tchougounova E, Kastemar M, Brasater D, Holland EC, Westermark B, Uhrbom L. Loss of Arf causes tumor progression of PDGFB-induced oligodendroglioma. Oncogene. 2007;26:6289–96.
   PubMed Web of Science ®Google Scholar
• Westermark UK, Lindberg N, Roswall P, Bråsäter D, Helgadottir HR, Hede SM, RAD51 can inhibit PDGF-B-induced gliomagenesis and genomic instability. Neuro Oncol. 2011;13:1277–87.
   PubMed Web of Science ®Google Scholar
• Assanah M, Lochhead R, Ogden A, Bruce J, Goldman J, Canoll P. Glial progenitors in adult white matter are driven to form malignant gliomas by platelet-derived growth factor-expressing retroviruses. J Neurosci. 2006;26:6781–90.
   PubMed Web of Science ®Google Scholar
• Assanah MC, Bruce JN, Suzuki SO, Chen A, Goldman JE, Canoll P. PDGF stimulates the massive expansion of glial progenitors in the neonatal forebrain. Glia. 2009;57:1835–47.
   PubMed Web of Science ®Google Scholar
• Appolloni I, Calzolari F, Tutucci E, Caviglia S, Terrile M, Corte G, PDGF-B induces a homogeneous class of oligodendrogliomas from embryonic neural progenitors. Int J Cancer. 2009;124:2251–9.
   PubMed Web of Science ®Google Scholar
• Calzolari F, Appollini I, Tutucci E, Caviglia S, Terrile M, Corte G, Tumor progression and oncogene addiction in a PDGF-B-induced model of gliomagenesis. Neoplasia. 2008;10:1373–82.
   PubMed Web of Science ®Google Scholar
• Hede SM, Hansson I, Afink GB, Eriksson A, Nazarenko I, Andrae J, GFAP promoter driven transgenic expression of PDGFB in the mouse brain leads to glioblastoma in a Trp53 null background. Glia. 2009;57:1143–53.
   PubMed Web of Science ®Google Scholar
• Nazarenko I, Hedrén A, Sjödin H, Orrego A, Andrae J, Afink GB, Brain abnormalities and glioma-like lesions in mice overexpressing the long isoform of PDGF-A in astrocytic cells. PLoS One. 2011;6:e18303.
   Web of Science ®Google Scholar
• Raff M. Glial cell diversification in the rat optic nerve. Science. 1989;243:1450–5.
   PubMed Web of Science ®Google Scholar
• Raff MC, Miller RH, Noble M. A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on the culture medium. Nature. 1983;303:390–6.
   PubMed Web of Science ®Google Scholar
• Gil-Perotin S, Marin-Husstege M, Li J, Soriano-Navarro M, Zindy F, Roussel MF, Loss of p53 induces changes in the behavior of subventricular zone cells: implication for the genesis of glial tumors. J Neurosci. 2006;26:1107–16.
   PubMed Web of Science ®Google Scholar